About NKGen Biotech NKGen is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic NK cell therapeutics. NKGen is ...

Q2 2025 Earnings Call Transcript September 15, 2025 Dave & Buster’s Entertainment, Inc. misses on earnings expectations.

NEW YORK – Nvidia, the world's leading chipmaker, announced on Thursday that it's investing $5 billion in Intel and it will ...

Australia has set a new target of reducing its greenhouse gas emissions by between 62% and 70% below 2005 levels by 2035.

Biogen to drive end-to-end development and commercialization of ThecaFlex DRx™, an investigational implantable device for intrathecal delivery of ...

Health Secretary Robert F. Kennedy Jr.'s new vaccine advisory committee is set to meet for a two-day session. The focus is on vaccines for COVID-19, hepatitis B, and chickenpox. Votes are ...

Looking ahead to our next fiscal year, we will be sharing with the board and the community a few highlights for our taxpayers ...

The weekend brings Fall Pec Thing, Midtown Strong Block Party, Senior Expo and Leanne Morgan, along with fundraisers, live ...

Deutsche Börse posted in-line Q2 results with no guidance changes or catalysts, while valuation stays stretched vs. peers.

The family philanthropy of hedge fund billionaire George Soros has consistently been one of the largest funders of human ...

September 17, 2025General Mills, Inc. beats earnings expectations. Reported EPS is $0.86, expectations were $0.815. Operator: Good morning, and welcome to General Mills' First Quarter Fiscal 2026 ...

Follow the latest developments on the final day of Donald Trump's state visit to the UK as the US President heads to Chequers ...